NOVOTECH HEALTH HOLDINGS PTE LTD

×

错误信息

  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined variable: termlist 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Warning: in_array() expects parameter 2 to be array, null given 在 eval() (行 100/var/www/7/modules/php/php.module(80) : eval()'d code).

Associated tags: Drug development, Asia-Pacific, CRO, Fine chemical, Clinical trial, Lists of people executed in the United States, Acceleration, Cros, City, Prospection

Novotech Receives "Best Biologics CRO Award 2022" at Korea Bioprocessing Excellence Awards 2022

Retrieved on: 
星期二, 六月 28, 2022 - 11:00pm

Novotech Country Managing Director Sanghee Kim said the Korea team was extremely pleased to receive this award in recognition of the clinical excellence provided to clients in the biologics sector.

Key Points: 
  • Novotech Country Managing Director Sanghee Kim said the Korea team was extremely pleased to receive this award in recognition of the clinical excellence provided to clients in the biologics sector.
  • Novotech now has a workforce of ~2,500 clinical trial professionals across Australia, New Zealand, South Korea, Greater China, Southeast Asia, India, South Africa and the US.
  • Ltd. ("Novotech") is the leading Asia-Pacific and US biotech specialist CRO.
  • Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases.

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

Retrieved on: 
星期四, 六月 23, 2022 - 12:00am

CHICAGO, IL, June 23, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022).

Key Points: 
  • CHICAGO, IL, June 23, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022).
  • Novotech CEO Dr. John Moller said the company was extremely pleased to receive this award for the second consecutive year.
  • https://novotech-cro.com/contact
    Clinical Leader and Life Science Leader working with Industry Standard Research (ISR), selected Novotech for the CRO Leadership Award.
  • According to the CRO Leadership Award research team: "The awards are based on customer feedback.

SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development

Retrieved on: 
星期三, 六月 15, 2022 - 12:30am

This meeting offers a neutrally organized forum to discuss lessons learned and better prepare the healthcare system for the next challenges.

Key Points: 
  • This meeting offers a neutrally organized forum to discuss lessons learned and better prepare the healthcare system for the next challenges.
  • That includes emerging technologies, innovations in cancer care, digital health and improved patient access to novel therapies.
  • The session will discuss benefits of digital health, personalised care and what is necessary to improve application in the region.
  • Ali Al dalaan (SFDA) will present his view on regulatory convergence and discuss with industry leaders how to improve patient access through regulatory agility.

Novotech's APAC and USA Leadership Teams at BIO 2022

Retrieved on: 
星期二, 六月 14, 2022 - 2:00pm

#4907

Key Points: 
  • #4907
    Book a meeting with one of the Novotech experts at BIO here.
  • Novotech now has a workforce of ~2,500 clinical trial professionals across Australia, South Korea, Greater China, Southeast Asia, India, South Africa and the US.
  • The APAC region was the largest contributor, with more than 50% of the trials followed by the US (29%) and the EU5 (17%).
  • It has been instrumental in the success of approximately 3,700 clinical trials across a broad range of therapeutic areas.